The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity

ICI-related hepatotoxicity (IRH) is becoming more and more common as immune checkpoint inhibitors (ICIs) have begun to be increasingly approved and used in combination with other anti-tumor drugs worldwide. Steroids are the first choice for the treatment of IRH, but the subsequent optimal treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Hui, Wang, Yang, Qu, Bo, Wei, Qiang, Li, Cuihua, Pan, Chao, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842701/
https://www.ncbi.nlm.nih.gov/pubmed/36623392
http://dx.doi.org/10.1016/j.tranon.2023.101619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842701/
https://www.ncbi.nlm.nih.gov/pubmed/36623392
http://dx.doi.org/10.1016/j.tranon.2023.101619

Ejemplares similares